Rechercher

Tapez ici pour rechercher le contenu associé sur le site Web

Rechercher

Afficher les résultats pour
  • Pages ()
  • Blog ()
  • Dans les nouvelles ()
  • Communiqué de presse ()
  • Événements ()
  • Webinaires ()
  • Ressources ()
  • Réussites ()
lightbulb

IDBS Blog

Select a category
Keyword search
Select a tag
  • Are you still using email and PDFs for external collaboration?

    Pharma and biotech companies have invested heavily in externalized research, development, and manufacturing in recent years – but their methods of sharing critical data are still rarely fit for purpose. Typically, collaborator data is simply packaged up in a PDF format and sent via email. Job well done, right?...

    Read more

  • Working with CROs: are you ready to future-proof your business?

    Despite shrinking growth in the pharmaceutical market, from double to single digit growth rates, demand for contract research organization (CRO) services is growing rapidly, according to the Business Research Company’s (BRC’s) 2018 CRO Global Market Report. Affirming CROs are on the rise, LabCorp, the world’s leading healthcare diagnostics company, has...

    Read more

  • The Bioprocessing Summit 2018: Our thoughts from Boston

    In August we attended The BioProcessing Summit 2018 in Boston. The event saw more than 1,000 bioprocess professionals and business leaders from around the globe gather to share practical ideas and solutions on tackling today’s bioprocess challenges. Now in its tenth year, The BioProcessing Summit is a week-long programme...

    Read more

  • Why should I go to i3 Austin?

    In October last year, we hosted our first ever i3 conference in North America. We enjoyed the event so much that i3 is back again this year – and this time we’re in Austin! So, why should you come to our Austin event? i3 is our premier annual customer...

    Read more

  • How technology can protect data in the world of outsourcing

    Pharmaceutical companies are under escalating pressure to significantly increase the number of drugs that reach the market within a shorter timeframe, but lack the infrastructure to do so. More than ever, companies need to partner with outside firms to compress the timeline of drug development, thereby decreasing overall cost...

    Read more

  • Overcoming current challenges in bioprocess development

    At the dawn of bioprocess development, biopharmaceutical manufacturing, upstream and downstream primary processing were worlds apart. This is because, in the pre-biotech days of industrial bioprocessing, the professionals in upstream, usually biologists, microbiologists, biochemists, and chemists, worked independently from the downstream professionals who were mostly chemical engineers working on...

    Read more

  • How can biologics R&D labs reach their full potential?

    Understanding the volume and complexity of data created throughout the scientific process is key. Biopharmaceutical companies generate a vast amount of high-value process data that is typically stored in paper records, databases, electronic files and in the heads of key personnel. This makes obtaining an holistic view of the...

    Read more

  • The future of biologics drug development is today

    These are exciting times in biologics. Since 1995, applications for biotech patents have increased 25% year-on-year and biologics currently make up more than 50% of drugs in development. And, with many big deals already on the ledger this year, 2018 is on track to be a popular one in...

    Read more

  • How your LIMS can help reduce the QC burden in bioanalysis

    The quality of your bioanalytical process will determine the quality of your study and with the right solution, the entire process can flow with a seamless assurance. As the primary impact on your study timeline occurs during the audit and review phase, isn’t it best to pick a solution...

    Read more

  • Can cloud computing streamline your R&D?

    Strict regulations, tight budgets and changing compliance needs are forcing pharma companies to employ new technology. Many are turning to cloud technology because it provides true scalability and helps free up time and resources that can be refocused on mission-critical or strategic projects. The resulting productivity, alongside the operational...

    Read more

  • 1
  • 2
  • 3
  • 4
  • ...
  • 25
  • »